PPARgamma and the pathobiology of pulmonary arterial hypertension
- PMID: 20204748
- DOI: 10.1007/978-1-60761-500-2_29
PPARgamma and the pathobiology of pulmonary arterial hypertension
Abstract
Peroxisome proliferator-activated receptor gamma (PPARgamma) is a nuclear receptor that functions as a transcription factor to regulate adipogenesis and metabolism by binding to PPAR response elements (PPAREs) in the promoter region of various target genes. Activation of PPARgamma suppresses smooth muscle cell proliferation and migration. This chapter discusses the potential protective role of PPARgamma and its downstream signaling cascades in the development of pulmonary arterial hypertension. Furthermore, the chapter also provides an overview on the cellular and molecular mechanisms involved in PPARgamma-mediated inhibitory effect on pulmonary vascular remodeling, a major contributor to the elevated pulmonary vascular resistance in patients with pulmonary arterial hypertension.
Similar articles
-
PPARgamma activation: a potential treatment for pulmonary hypertension.Sci Transl Med. 2009 Dec 23;1(12):12ps14. doi: 10.1126/scitranslmed.3000267. Sci Transl Med. 2009. PMID: 20371457 Review.
-
Peroxisome proliferator-activated receptor γ attenuates serotonin-induced pulmonary artery smooth muscle cell proliferation and apoptosis inhibition involving ERK1/2 pathway.Microvasc Res. 2015 Jul;100:17-24. doi: 10.1016/j.mvr.2015.04.008. Epub 2015 Apr 30. Microvasc Res. 2015. PMID: 25937083
-
Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.Am J Respir Cell Mol Biol. 2016 Jan;54(1):136-46. doi: 10.1165/rcmb.2014-0337OC. Am J Respir Cell Mol Biol. 2016. PMID: 26098770 Free PMC article.
-
Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor.Hypertension. 2012 Dec;60(6):1471-8. doi: 10.1161/HYPERTENSIONAHA.112.198887. Epub 2012 Oct 29. Hypertension. 2012. PMID: 23108648
-
PPARγ is a gatekeeper for extracellular matrix and vascular cell homeostasis: beneficial role in pulmonary hypertension and renal/cardiac/pulmonary fibrosis.Curr Opin Nephrol Hypertens. 2020 Mar;29(2):171-179. doi: 10.1097/MNH.0000000000000580. Curr Opin Nephrol Hypertens. 2020. PMID: 31815758 Review.
Cited by
-
The role of mitochondria in pulmonary vascular remodeling.J Mol Med (Berl). 2010 Oct;88(10):1003-10. doi: 10.1007/s00109-010-0670-x. Epub 2010 Aug 24. J Mol Med (Berl). 2010. PMID: 20734021 Review.
-
Perinatal Nutritional and Metabolic Pathways: Early Origins of Chronic Lung Diseases.Front Med (Lausanne). 2021 Jun 15;8:667315. doi: 10.3389/fmed.2021.667315. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34211985 Free PMC article. Review.
-
Cannabinoids-A New Perspective in Adjuvant Therapy for Pulmonary Hypertension.Int J Mol Sci. 2021 Sep 17;22(18):10048. doi: 10.3390/ijms221810048. Int J Mol Sci. 2021. PMID: 34576212 Free PMC article. Review.
-
Critical effects of epigenetic regulation in pulmonary arterial hypertension.Cell Mol Life Sci. 2017 Oct;74(20):3789-3808. doi: 10.1007/s00018-017-2551-8. Epub 2017 Jun 1. Cell Mol Life Sci. 2017. PMID: 28573430 Free PMC article. Review.
-
PPARγ Interaction with UBR5/ATMIN Promotes DNA Repair to Maintain Endothelial Homeostasis.Cell Rep. 2019 Jan 29;26(5):1333-1343.e7. doi: 10.1016/j.celrep.2019.01.013. Cell Rep. 2019. PMID: 30699358 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical